Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 3, 2009, Pages 115-121

  Karpiński, Łukasz ^a,b   Płaksej, Rafał ^a   Derzhko, Roksolana ^a   Orda, Alina ^a   Witkowska, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

C reactive protein; Interleukin 10; Interleukin 6; Myocardial infarction (MI)

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

EID: 64149121931     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.624     Document Type: Article

References (24)

1. Frangogiannis NG, Smith CW, Entman ML, et al. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31-47.
2. Ohtsuka T, Harnada M, Inoue K, et al. Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction. Clin Cardiol. 2004; 27; 417-420.
3. Pepys MB, Hirschfield GM, Tennent GA, et al. C-reactive protein for the treatment of cardiovascular disease. Nature. 2006; 440: 1217-1221.
4. Kohno T, Anzai T, Naito K, et al. Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction. Cardiology. 2007;107:386-394.
5. Li JJ, Guo YL, Yang YJ. Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome. Med Hypotheses. 2005; 65:103-106.
6. Halvorsen B, Waehre T, Scholz H, et al. lnterleukin-10 enhances the ox idized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res. 2005; 46: 211-219.
7. Karpiński Ł, Płaksej R, Kosmala W, et al. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial information treated with primary angioplasty. Kardiol Pol. 2008; 66:1279-1285.
8. Debrunner M, Schuiki E, Minder E, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol. 2008; 97: 298-305.
9. Gabriel AS, Martinsson A, Wretlind B, et al. IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. Eur J Int Med. 2004; 15: 523-528.
10. Kucharz EJ, Wilk T. Dynamics of serum interleukin-6 level in patients with acute myocardial infarction. Eur J Int Med. 2000; 11: 253-256.
11. Miyao Y, Yasue H, Ogawa H, et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 1993; 126: 1299-1304.
12. Ziakas A, Gavrilidis S, Giannoglou G, et al. In-hospital and long-term prognostic value of fibrinogen, CRP and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis. Angiology. 2006; 57: 283-293.
13. Kotajima N, Kimura T, Kanda T, et al. Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction. Heart. 2001; 86: 704-705.
14. Bossowska A, Kiersnowska-Rogowska B, Bossowski A, et al. Cytokines in patients with ischaemic heart disease or myocardial infarction. Kardiol Pol. 2003; 59: 110-114.
15. Dedobbeleer C, Melot C, Renard M, et al. C-reactive protein increase in acute myocardial infarction. Acta Cardiol. 2004; 59: 291-296.
16. Jahn J, Hellman I, Maass M, et al. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome. Herz. 2004; 29: 795-801.
17. Xiaozftou H, Jie Z, Li Z, et al. Predictive value of the serum levels of N-terminal pro- brain natriuretic peptide and high-sensivity C-reactive protein in left ventricular remodeling after acute myocardial infarction. J Clin Lab Anal. 2006; 20: 19-22.
18. Heeschen C, Dimmeler S, Hamm CW, et al. for the CAPTURE Study Investigators. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation. 2003; 107:2109-2114.
19. Frangogiannis NG, Mendoga LH, Lindley ML. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000; 5: 2798-2808.
20. Milosz D, Czupryniak L, Saryusz-Wolska M, et al. [Adiponectinemia, inflammatory process activity, and endothelial dysfunction in patients with type 2 diabetes and acute coronary syndrome with ST elevation in relation to the severity of lesions in the coronary arteries). Pol Arch Med Wewn. 2007;117:343-349. Polish.
21. Wojakowski W, Maślankiewicz K, Ochala A, et al. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina. Int J Mol Med. 2004; 14: 317-322.
22. Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factor: a population based cross sectional study. BMJ. 1996;312:1061-1065.
23. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997;78:273-277.
24. Rywik S, Wa̧growska H, Piotrowski W. [Epidemiology of obesity as a risk factor for diseases of the circulatory system]. Pol Tyg Lek. 1995; 50 (Suppl. I): 63-67. Polish.